US Broker Ratings

Globus Medical, Inc. (GMED) Stock Analysis: 40% Potential Upside in the Healthcare Sector

Globus Medical, Inc. (NYSE: GMED), a prominent player in the healthcare sector, specifically within the medical devices industry, presents an intriguing opportunity for investors. With a market capitalization of $7.64..

Alkermes plc (ALKS) Stock Analysis: Investor Outlook with a 33.82% Potential Upside

For investors seeking opportunities in the healthcare sector, Alkermes plc (NASDAQ: ALKS) presents a compelling case. This Dublin-based biopharmaceutical company stands out with its focus on addressing unmet medical needs..

Vaxcyte, Inc. (PCVX) Stock Analysis: A Promising 143% Upside Potential for Biotech Investors

Vaxcyte, Inc. (NASDAQ: PCVX) has emerged as a focal point for investors seeking high-growth opportunities in the biotechnology sector. With its cutting-edge approach to vaccine development, Vaxcyte is carving a..

Verona Pharma plc (VRNA) Stock Report: Evaluating the Potential of a Biotech Powerhouse with a $9.09 Billion Market Cap

Verona Pharma plc (NASDAQ: VRNA), a prominent player in the healthcare sector, is capturing investor attention with its substantial $9.09 billion market capitalization. As a biopharmaceutical company headquartered in London,..

Corcept Therapeutics (CORT) Stock Analysis: A Promising 82.87% Upside in the Biotech Sector

Corcept Therapeutics Incorporated (NASDAQ: CORT) stands out in the biotechnology industry, promising significant growth potential amid its innovative therapeutic developments. The company, headquartered in Redwood City, California, specializes in discovering..

Viatris Inc. (VTRS) Stock Analysis: Exploring a 17.34% Potential Upside Amidst Healthcare Sector Dynamics

Viatris Inc. (NASDAQ: VTRS), a prominent player in the healthcare sector, is capturing investor attention with its significant market presence and a potential upside of 17.34%, based on the average..

Cencora, Inc. (COR) Stock Analysis: Healthcare Giant’s Robust Growth and Strategic Positioning

Cencora, Inc. (NYSE: COR), a key player in the healthcare sector, has recently undergone significant changes that could position it for robust growth. Formerly known as AmerisourceBergen Corporation, the company..

Amgen Inc. (AMGN) Investor Outlook: Navigating a 7.42% Potential Upside Amidst Strong Revenue Growth

Amgen Inc. (NASDAQ: AMGN), a titan in the healthcare sector, stands as a formidable player in the drug manufacturing industry. With a market capitalization of $156.19 billion, Amgen continues to..

Medpace Holdings, Inc. (MEDP) Stock Analysis: Balancing Robust Growth with Valuation Concerns

Medpace Holdings, Inc. (NASDAQ: MEDP), a pivotal player in the Healthcare sector’s Diagnostics & Research industry, commands attention with its impressive market cap of $14.08 billion. Headquartered in Cincinnati, Ohio,..

Hologic, Inc. (HOLX) Stock Analysis: Exploring Growth Potential Amidst a 7.84% Upside

Hologic, Inc. (NASDAQ: HOLX) stands as a significant player in the healthcare sector, specializing in medical instruments and supplies with a core focus on women’s health. From diagnostics to surgical..

AptarGroup, Inc. (ATR) Investor Outlook: Strong Buy Ratings and 34% Upside Potential

AptarGroup, Inc. (NYSE: ATR) is making waves in the Healthcare sector, specifically within the Medical Instruments & Supplies industry. With a robust market capitalization of $8.63 billion, this Crystal Lake,..

Bruker Corporation (BRKR) Stock Analysis: Unpacking a 31.67% Potential Upside Amidst Market Volatility

Investors eyeing opportunities in the healthcare sector may find Bruker Corporation (NASDAQ: BRKR) a compelling candidate for their portfolios. This Massachusetts-based company, with a market capitalization of $5.35 billion, operates..

Madrigal Pharmaceuticals, Inc. (MDGL) Stock Analysis: Potential Upside in the High-Stakes Biotech Arena

Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL), a prominent player in the biotechnology sector, has been garnering significant attention from investors, driven by its innovative approach to treating metabolic dysfunction-associated steatohepatitis (MASH)...

HealthEquity, Inc. (HQY) Stock Analysis: Exploring a 34.58% Potential Upside and Strong Buy Ratings

HealthEquity, Inc. (NASDAQ: HQY) stands out as a robust player in the healthcare sector, particularly in the health information services industry. With a market capitalization of $7.8 billion, HealthEquity is..

Regencell Bioscience Holdings (RGC) Stock Report: Is This High-Volatility Play Worth the Risk?

Regencell Bioscience Holdings Limited (NASDAQ: RGC) is stirring interest in the healthcare sector, specifically within the drug manufacturing industry. As a Traditional Chinese Medicine (TCM) bioscience company based in Hong..

United Therapeutics Corporation (UTHR) Stock Analysis: Unpacking a Promising 12% Upside Potential

United Therapeutics Corporation (NASDAQ: UTHR), a leading player in the healthcare sector, stands out with its focus on addressing critical unmet medical needs through its innovative products. With a market..

GE HealthCare Technologies Inc. (GEHC) Stock Analysis: A 22.96% Potential Upside Beckons Investors

GE HealthCare Technologies Inc. (NYSE: GEHC), a prominent player in the healthcare sector, is capturing investor attention with its substantial market presence and promise of significant upside. With a market..

Medtronic plc (MDT) Stock Analysis: Exploring Growth Potential and Dividend Stability

Medtronic plc (NYSE: MDT), a stalwart in the medical devices industry, offers a compelling investment opportunity for those seeking a blend of growth and dividend yield. With a market capitalization..

Grifols, S.A. (GRFS) Stock Analysis: Exploring a 30.74% Potential Upside in the Healthcare Sector

Grifols, S.A. (GRFS), a cornerstone in the healthcare sector, is drawing investor attention with its promising potential upside of 30.74%. As a key player in the drug manufacturing industry, this..

Veeva Systems Inc. (VEEV) Stock Analysis: Analyzing Growth Potential with 11.51% Upside

Veeva Systems Inc. (NYSE: VEEV) continues to solidify its position as a leader in the health information services sector by providing innovative cloud-based solutions tailored specifically for the life sciences..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds